Response to: “A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial”
oleh: Annelise Madison, Barbara L. Andersen, Ali Ajam
| Format: | Article |
|---|---|
| Diterbitkan: | BMC 2019-02-01 |
Deskripsi
No description available for this item.